Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	LRR_8	NTRK2 LRRIQ4 LRRTM3 ADGRA2 LRRC8D PRELP LRRC8B CD180 ADGRA3	3.77e-06	171	133	9	PF13855
Domain	LRR_1	NTRK2 LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	3.85e-06	219	133	10	PF00560
Domain	GPS	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	4.00e-06	34	133	5	SM00303
Domain	GPS	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	4.64e-06	35	133	5	PF01825
Domain	LRR_TYP	LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	5.00e-06	177	133	9	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	5.00e-06	177	133	9	IPR003591
Domain	GPS	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	5.36e-06	36	133	5	PS50221
Domain	GPS	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	6.16e-06	37	133	5	IPR000203
Domain	GPCR_2_extracellular_dom	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	9.15e-06	40	133	5	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	9.15e-06	40	133	5	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	9.15e-06	40	133	5	PS50227
Domain	LRR	LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	1.39e-05	201	133	9	PS51450
Domain	Leu-rich_rpt	NTRK2 LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	2.47e-05	271	133	10	IPR001611
Domain	7tm_2	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	2.78e-05	50	133	5	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	2.78e-05	50	133	5	PS00650
Domain	IPT	PLXNA3 PKHD1 NFAT5 PLXNA1	3.80e-05	27	133	4	SM00429
Domain	HRM	ADGRB2 ADGRB3 ADGRA2 ADGRA3	4.41e-05	28	133	4	PF02793
Domain	TIG	PLXNA3 PKHD1 NFAT5 PLXNA1	6.66e-05	31	133	4	PF01833
Domain	GPCR_2_secretin-like	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	6.77e-05	60	133	5	IPR000832
Domain	GPCR_2-like	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	6.77e-05	60	133	5	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	7.34e-05	61	133	5	PS50261
Domain	IPT	PLXNA3 PKHD1 NFAT5 PLXNA1	7.57e-05	32	133	4	IPR002909
Domain	-	NTRK2 LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	1.02e-04	321	133	10	3.80.10.10
Domain	L_dom-like	NTRK2 LRRIQ4 LRRTM3 ADGRA2 LRRC8D LRRC46 PRELP LRRC8B CD180 ADGRA3	1.22e-04	328	133	10	IPR032675
Domain	GPCR_2_brain_angio_inhib	ADGRB2 ADGRB3	1.50e-04	3	133	2	IPR008077
Domain	LRRC8_Pannexin-like	LRRC8D LRRC8B	4.96e-04	5	133	2	IPR021040
Domain	Pannexin_like	LRRC8D LRRC8B	4.96e-04	5	133	2	PF12534
Domain	Spectrin	DST SYNE2 MACF1	5.63e-04	23	133	3	PF00435
Domain	ACTININ_2	DST SYNE2 MACF1	5.63e-04	23	133	3	PS00020
Domain	ACTININ_1	DST SYNE2 MACF1	5.63e-04	23	133	3	PS00019
Domain	Actinin_actin-bd_CS	DST SYNE2 MACF1	5.63e-04	23	133	3	IPR001589
Domain	-	DST MACF1	7.41e-04	6	133	2	3.90.1290.10
Domain	GAR	DST MACF1	7.41e-04	6	133	2	PS51460
Domain	GAS2	DST MACF1	7.41e-04	6	133	2	PF02187
Domain	-	DST MACF1	7.41e-04	6	133	2	3.30.920.20
Domain	GAS_dom	DST MACF1	7.41e-04	6	133	2	IPR003108
Domain	GAS2	DST MACF1	7.41e-04	6	133	2	SM00243
Domain	Plectin	DST MACF1	1.03e-03	7	133	2	PF00681
Domain	Plectin_repeat	DST MACF1	1.03e-03	7	133	2	IPR001101
Domain	PLEC	DST MACF1	1.03e-03	7	133	2	SM00250
Domain	Spectrin_repeat	DST SYNE2 MACF1	1.13e-03	29	133	3	IPR002017
Domain	SPEC	DST SYNE2 MACF1	1.51e-03	32	133	3	SM00150
Domain	Spectrin/alpha-actinin	DST SYNE2 MACF1	1.51e-03	32	133	3	IPR018159
Domain	CH	CFAP47 DST SYNE2 MACF1	1.57e-03	70	133	4	PF00307
Domain	-	CFAP47 DST SYNE2 MACF1	1.65e-03	71	133	4	1.10.418.10
Domain	Plexin_cytopl	PLXNA3 PLXNA1	1.75e-03	9	133	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA1	1.75e-03	9	133	2	IPR013548
Domain	Plexin	PLXNA3 PLXNA1	1.75e-03	9	133	2	IPR031148
Domain	GPCR_2_secretin-like_CS	ADGRB3 ADGRA2 ADGRG6	1.80e-03	34	133	3	IPR017983
Domain	CH	CFAP47 DST SYNE2 MACF1	1.83e-03	73	133	4	PS50021
Domain	CH-domain	CFAP47 DST SYNE2 MACF1	2.02e-03	75	133	4	IPR001715
Domain	GAIN_dom_N	ADGRB2 ADGRB3	2.65e-03	11	133	2	IPR032471
Domain	GAIN	ADGRB2 ADGRB3	2.65e-03	11	133	2	PF16489
Domain	Cys-rich_flank_reg_C	NTRK2 ADGRA2 CD180 ADGRA3	3.91e-03	90	133	4	IPR000483
Domain	LRRCT	NTRK2 ADGRA2 CD180 ADGRA3	3.91e-03	90	133	4	SM00082
Domain	FERM_M	EPB41L5 KRIT1 TLN2	4.29e-03	46	133	3	PF00373
Domain	-	EPB41L5 KRIT1 TLN2	5.12e-03	49	133	3	1.20.80.10
Domain	FERM_central	EPB41L5 KRIT1 TLN2	5.12e-03	49	133	3	IPR019748
Domain	FERM_domain	EPB41L5 KRIT1 TLN2	5.12e-03	49	133	3	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	IPR014352
Domain	FERM_1	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	PS00660
Domain	FERM_2	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	PS00661
Domain	FERM_3	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	PS50057
Domain	Band_41_domain	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	IPR019749
Domain	B41	EPB41L5 KRIT1 TLN2	5.42e-03	50	133	3	SM00295
Domain	Integrin_alpha_C_CS	ITGA2 ITGAM	5.66e-03	16	133	2	IPR018184
Domain	LRRNT	NTRK2 LRRTM3 PRELP	6.38e-03	53	133	3	PF01462
Domain	Ig_E-set	PLXNA3 PKHD1 NFAT5 PLXNA1	6.53e-03	104	133	4	IPR014756
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	RTEL1 ADGRB3 SMC5 ADGRA2 ESYT2 DST ZNRF3 UBR5 SYNE2 MACF1 TLN2 NIN	1.19e-10	225	138	12	12168954
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SP100 ZCCHC8 HMGXB4 ZKSCAN2 SCEL ZFHX4 ZNRF3 UBR5 ZFP91 SCAPER MACF1 CEP295 LRRC8B CRYBG3 RAPGEF2 CLSPN PCM1 KNL1 NIN	9.93e-08	1116	138	19	31753913
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	1.01e-07	29	138	5	15203201
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRB2 ADGRB3 ADGRA2 ADGRG6 ADGRA3	1.98e-07	33	138	5	25713288
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYO5A NTRK2 ADGRB2 ADGRB3 EDC4 CYRIB ADD1 DST AP2B1 UBR5 SYNE2 MACF1 TLN2 MAPK1 RAPGEF2 PCM1	1.51e-06	963	138	16	28671696
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	EDC4 ADD1 ESYT2 DST UBR5 MACF1 CRYBG3 PCM1	2.02e-06	209	138	8	36779422
Pubmed	There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini.	ADGRA2 ADGRG6 ADGRA3	2.11e-06	7	138	3	12565841
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYO5A ZCCHC8 EDC4 TASOR2 DST AP2B1 UBR5 SYNE2 NUP210 MACF1 RRP7A PCM1 CAP1	2.21e-06	653	138	13	22586326
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	SP100 HMGXB4 EPB41L5 KRT73 DST AP2B1 ZFP91 MACF1 TLN2 CRYBG3 KNL1	3.14e-06	472	138	11	38943005
Pubmed	Large-scale death of retinal astrocytes during normal development is non-apoptotic and implemented by microglia.	ITGAM CSF1R MERTK	7.19e-06	10	138	3	31626642
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	MYO5A ADGRB2 ADGRB3 UBR5 MACF1 TLN2 MAPK1 RAPGEF2	7.79e-06	251	138	8	27507650
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	CCDC168 NUP62 FSIP2 DST SYNE2 ZNF292	1.02e-05	123	138	6	26912792
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	ADD1 SYNE2 MACF1 NIN	1.42e-05	37	138	4	27565344
Pubmed	Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase.	ABCB11 MAPK1	1.56e-05	2	138	2	14762791
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	1.56e-05	2	138	2	11002341
Pubmed	Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis.	ADGRB2 ADGRB3	1.56e-05	2	138	2	12218411
Pubmed	Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen.	CSF1R CTSK	1.56e-05	2	138	2	33607650
Pubmed	Assembly of centrosomal proteins and microtubule organization depends on PCM-1.	PCM1 NIN	1.56e-05	2	138	2	12403812
Pubmed	Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells.	CSF1R MERTK	1.56e-05	2	138	2	31042769
Pubmed	Extracellular signal-regulated protein kinase 2 is required for efficient generation of B cells bearing antigen-specific immunoglobulin G.	CD19 MAPK1	1.56e-05	2	138	2	17145771
Pubmed	Co-ordinated expression of lymphoid and myeloid specific transcription factors during B-1b cell differentiation into mononuclear phagocytes in vitro.	ITGAM CD19	1.56e-05	2	138	2	18710404
Pubmed	Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446.	DUSP16 MAPK1	1.56e-05	2	138	2	12794087
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	MYO5A ADGRB2 AP2B1 UBR5 MACF1 TLN2 MAPK1 RAPGEF2	1.76e-05	281	138	8	28706196
Pubmed	A human MAP kinase interactome.	SP100 USF3 DST AP2B1 DUSP16 MACF1 MAPK1 RAPGEF2 USF2 CPLANE1	2.60e-05	486	138	10	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SYNE2 TLN2 RAPGEF2 FBXO21 ZNF292	2.60e-05	87	138	5	12465718
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJB12 MYO5A RTEL1 B3GALNT2 LRRC8D TASOR2 ADGRG6 ESYT2 USF3 FUBP1 NUP210 MACF1 RAPGEF2 NFAT5 FBXO21 VPS13B PCM1 FAM149A	2.60e-05	1489	138	18	28611215
Pubmed	Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR -21-Peli1-c-Rel Pathway Prevents Autoimmunity.	KRIT1 ESYT2 FUBP1	3.30e-05	16	138	3	32414810
Pubmed	TrkB-dependent EphrinA reverse signaling regulates callosal axon fasciculate growth downstream of Neurod2/6.	PLXNA3 NTRK2 MAPK1 PLXNA1	3.71e-05	47	138	4	35462405
Pubmed	Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia.	ITGAM CSF1R MERTK	3.99e-05	17	138	3	30647151
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ZCCHC8 EPB41L5 NUP62 EDC4 FSIP2 ESYT2 DST SYNE2 MACF1 NR3C2 CRYBG3 RAPGEF2 PCM1	4.12e-05	861	138	13	36931259
Pubmed	Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing.	SYNE2 MAPK1	4.68e-05	3	138	2	25744025
Pubmed	Expression of the mouse Macf2 gene during inner ear development.	DST MACF1	4.68e-05	3	138	2	12399109
Pubmed	Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.	CSF1R MAPK1	4.68e-05	3	138	2	25757564
Pubmed	Body temperature measurement in mice during acute illness: implantable temperature transponder versus surface infrared thermometry.	ITGAM MERTK	4.68e-05	3	138	2	29476115
Pubmed	Rapgef2, a guanine nucleotide exchange factor for Rap1 small GTPases, plays a crucial role in adherence junction (AJ) formation in radial glial cells through ERK-mediated upregulation of the AJ-constituent protein expression.	MAPK1 RAPGEF2	4.68e-05	3	138	2	28917843
Pubmed	Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia.	MAPK1 USF2	4.68e-05	3	138	2	11583024
Pubmed	Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1).	ADGRB2 ADGRB3	4.68e-05	3	138	2	9533023
Pubmed	Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma.	ADGRB2 ADGRB3	4.68e-05	3	138	2	15225653
Pubmed	An essential role for talin during alpha(M)beta(2)-mediated phagocytosis.	ITGAM TLN2	4.68e-05	3	138	2	17202407
Pubmed	Direct binding of the human homologue of the Drosophila disc large tumor suppressor gene to seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5), and a novel TEM5-like protein.	ADGRA2 ADGRA3	4.68e-05	3	138	2	15021905
Pubmed	Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.	ITGA2 ITGAM	4.68e-05	3	138	2	28669815
Pubmed	Identification of plexin family molecules in mice.	PLXNA3 PLXNA1	4.68e-05	3	138	2	8806646
Pubmed	Differential expression of plexin-A subfamily members in the mouse nervous system.	PLXNA3 PLXNA1	4.68e-05	3	138	2	11241833
Pubmed	RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.	CD19 RAPGEF2	4.68e-05	3	138	2	20595512
Pubmed	Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP: MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION.	NTRK2 MAPK1	4.68e-05	3	138	2	26574547
Pubmed	Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.	PKHD1 ABCB11	4.68e-05	3	138	2	25771912
Pubmed	Myeloid translocation gene 16b is a dual A-kinase anchoring protein that interacts selectively with plexins in a phospho-regulated manner.	PLXNA3 PLXNA1	4.68e-05	3	138	2	20138877
Pubmed	Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KIAA0825 UBR5 NUP210 NFAT5 FBXO21	5.09e-05	100	138	5	10048485
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYO5A ZCCHC8 ZBTB43 ADGRB3 MOAP1 KRIT1 FOCAD POLR3B DST AP2B1 MACF1 TLN2 MERTK RAPGEF2 PCM1 ZNF292	5.35e-05	1285	138	16	35914814
Pubmed	Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins.	NTRK2 ADGRB2 ADGRB3 LRRTM3	5.54e-05	52	138	4	24613359
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ADGRB3 SMC5 NBEAL2 VPS13B ZNF292	6.42e-05	105	138	5	9628581
Pubmed	Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.	ITGA2 ITGAM MAPK1	6.63e-05	20	138	3	11438667
Pubmed	Age-dependent differences in efferocytosis determine the outcome of opsonophagocytic protection from invasive pathogens.	ITGAM MERTK	9.33e-05	4	138	2	37059107
Pubmed	Novel nuclear nesprin-2 variants tether active extracellular signal-regulated MAPK1 and MAPK2 at promyelocytic leukemia protein nuclear bodies and act to regulate smooth muscle cell proliferation.	SYNE2 MAPK1	9.33e-05	4	138	2	19861416
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA3 PLXNA1	9.33e-05	4	138	2	11306810
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA3 PLXNA1	9.33e-05	4	138	2	25518740
Pubmed	Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum.	ADCY10 MAPK1	9.33e-05	4	138	2	14741752
Pubmed	MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein.	DUSP16 MAPK1	9.33e-05	4	138	2	11489891
Pubmed	Determination of cell adhesion sites of neuropilin-1.	PLXNA3 PLXNA1	9.33e-05	4	138	2	10725340
Pubmed	Differential Interaction of Platelet-Derived Extracellular Vesicles With Circulating Immune Cells: Roles of TAM Receptors, CD11b, and Phosphatidylserine.	ITGAM MERTK	9.33e-05	4	138	2	30619243
Pubmed	A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.	PLXNA3 PLXNA1	9.33e-05	4	138	2	8570614
Pubmed	Dehydroepiandrosterone-induced phosphorylation and translocation of FoxO1 depend on the mineralocorticoid receptor.	NR3C2 MAPK1	9.33e-05	4	138	2	21747041
Pubmed	Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.	ITGAM CD19	9.33e-05	4	138	2	34470858
Pubmed	Interaction of KLRG1 with E-cadherin: new functional and structural insights.	MYO5A KLRG1	9.33e-05	4	138	2	19009530
Pubmed	Neurotrophin receptors TrkA and TrkB in retinoblastoma are differentially expressed depending on cellular differentiation.	NTRK2 MAPK1	9.33e-05	4	138	2	19816090
Pubmed	Loss of IP3 Receptor-Mediated Ca2+ Release in Mouse B Cells Results in Abnormal B Cell Development and Function.	ITPR2 CD19	9.33e-05	4	138	2	28615414
Pubmed	Cloning and characterization of mouse ACF7, a novel member of the dystonin subfamily of actin binding proteins.	DST MACF1	9.33e-05	4	138	2	8954775
Pubmed	Selective transport of neurotransmitters and modulators by distinct volume-regulated LRRC8 anion channels.	LRRC8D LRRC8B	9.33e-05	4	138	2	28193731
Pubmed	Brain-Derived Neurotrophic Factor Regulates Ishikawa Cell Proliferation through the TrkB-ERK1/2 Signaling Pathway.	NTRK2 MAPK1	9.33e-05	4	138	2	33302387
Pubmed	IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming.	ITPR2 CD19	9.33e-05	4	138	2	35494252
Pubmed	Anterograde C1ql1 signaling is required in order to determine and maintain a single-winner climbing fiber in the mouse cerebellum.	ADGRB2 ADGRB3	9.33e-05	4	138	2	25611509
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	DNAJB12 MYO9B ZCCHC8 WDR5 EXOC5 AP2B1 FUBP1 PCM1 GABRA4	1.01e-04	462	138	9	31138677
Pubmed	Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution.	WARS2 ITPR2 ZNRF3	1.16e-04	24	138	3	20935629
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	ADGRB2 ADGRB3 ADGRG6 MAPK1 NFAT5 ADGRA3	1.27e-04	193	138	6	20677014
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLXNA3 MYO9B ADGRB2 EDC4 ADGRA2 ITPR2 CCDC142 FOCAD DST ZNRF3 NBEAL2 DUSP16 TLN2 PLXNA1	1.34e-04	1105	138	14	35748872
Pubmed	Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.	CD19 MAPK1	1.55e-04	5	138	2	10706702
Pubmed	Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.	MOAP1 UBR5	1.55e-04	5	138	2	27721409
Pubmed	Renal Deletion of LRRC8/VRAC Channels Induces Proximal Tubulopathy.	LRRC8D LRRC8B	1.55e-04	5	138	2	35777784
Pubmed	Semaphorin 5A inhibits synaptogenesis in early postnatal- and adult-born hippocampal dentate granule cells.	PLXNA3 PLXNA1	1.55e-04	5	138	2	25313870
Pubmed	Infection-induced type I interferons activate CD11b on B-1 cells for subsequent lymph node accumulation.	ITGAM CD19	1.55e-04	5	138	2	26612263
Pubmed	LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins.	LRRC8D LRRC8B	1.55e-04	5	138	2	15094057
Pubmed	Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival.	NUP62 PRELP	1.55e-04	5	138	2	15572682
Pubmed	Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence.	ITGAM MERTK	1.55e-04	5	138	2	35481836
Pubmed	Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC.	LRRC8D LRRC8B	1.55e-04	5	138	2	24790029
Pubmed	Developmental origin, functional maintenance and genetic rescue of osteoclasts.	CSF1R CTSK	1.55e-04	5	138	2	30971820
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	DST SCAPER MACF1 NFAT5 FBXO21	1.76e-04	130	138	5	12421765
Pubmed	Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.	ZFHX4 FUBP1 NFAT5	1.86e-04	28	138	3	29365100
Pubmed	Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation.	RTEL1 EPG5 CRYBG3 ZNF292	1.88e-04	71	138	4	33541421
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PLXNA3 SP100 MYO5A NUP62 KRT73 TASOR2 C4orf17 DST AP2B1 KIAA0825 FUBP1 SYNE2 PKHD1 MACF1 CEP295 ZNF292	2.01e-04	1442	138	16	35575683
Pubmed	Integrin linked kinase (ILK) is required for lens epithelial cell survival, proliferation and differentiation.	ITGA2 DST MAPK1	2.29e-04	30	138	3	24472646
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MYO5A MYO9B NUP62 EDC4 ITPR2 DST UBR5 FUBP1 SYNE2 NUP210 MACF1 MAPK1 PCM1	2.30e-04	1024	138	13	24711643
Pubmed	Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.	NTRK2 MAPK1	2.32e-04	6	138	2	20442398
Pubmed	Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages.	PLXNA3 PLXNA1	2.32e-04	6	138	2	19480842
Pubmed	HIV-1 Nef perturbs the function, structure, and signaling of the Golgi through the Src kinase Hck.	CSF1R MAPK1	2.32e-04	6	138	2	21567396
Pubmed	The motheaten mutation rescues B cell signaling and development in CD45-deficient mice.	CD19 MAPK1	2.32e-04	6	138	2	9254656
Pubmed	Th17-associated cytokines promote human airway smooth muscle cell proliferation.	IL17RC MAPK1	2.32e-04	6	138	2	22898922
Pubmed	miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis.	CSF1R MAPK1	2.32e-04	6	138	2	26754294
Pubmed	An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo.	ITGAM MERTK	2.32e-04	6	138	2	24509082
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZBTB43 SMC5 EPG5 FOCAD UBR5 MACF1 NFAT5 VPS13B	2.32e-04	407	138	8	12693553
Pubmed	Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.	MYO9B ITPR2 ETAA1 PCM1 NIN	2.40e-04	139	138	5	25476789
GeneFamily	Immunoglobulin like domain containing\|Adhesion G protein-coupled receptors, subfamily A	ADGRA2 ADGRA3	8.34e-05	3	96	2	911
GeneFamily	Adhesion G protein-coupled receptors, subfamily B	ADGRB2 ADGRB3	8.34e-05	3	96	2	912
GeneFamily	Volume regulated anion channel subunits	LRRC8D LRRC8B	2.76e-04	5	96	2	1158
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	7.65e-04	8	96	2	939
GeneFamily	Plexins	PLXNA3 PLXNA1	9.80e-04	9	96	2	683
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	NTRK2 CSF1R MERTK	1.24e-03	40	96	3	321
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EPB41L5 KRIT1 TLN2	2.37e-03	50	96	3	1293
GeneFamily	DNA helicases	RTEL1 PIF1	3.60e-03	17	96	2	1167
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA2 ITGAM	4.04e-03	18	96	2	1160
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SP100 MYO9B HMGXB4 GCNT1 SMC5 KRIT1 ADGRG6 DST UBR5 FUBP1 SYNE2 MACF1 CRYBG3 RAPGEF2 VPS13B ADGRA3 ZNF292	2.52e-06	856	137	17	M4500
Coexpression	ZHENG_BOUND_BY_FOXP3	SP100 NFKBIZ GTDC1 TMEM71 ITPR2 ESYT2 USF3 SYNE2 ZFP91 MACF1 RAPGEF2 KNL1	1.26e-05	498	137	12	M1741
Coexpression	ZHENG_BOUND_BY_FOXP3	SP100 NFKBIZ GTDC1 TMEM71 ITPR2 ESYT2 USF3 SYNE2 ZFP91 MACF1 RAPGEF2 KNL1	1.50e-05	507	137	12	MM1030
Coexpression	GABRIELY_MIR21_TARGETS	SMC5 ESYT2 EXOC5 POLR3B UBR5 SYNE2 NFAT5 KNL1 ZNF292	2.22e-05	289	137	9	M2196
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	VPS11 MYO5A MYO9B SMC5 CYRIB ADD1 EPG5 ITPR2 ESYT2 UBR5 NBEAL2 NUP210 MACF1 MAPK1 USF2 NFAT5 VPS13B PCM1 CAP1 ZNF292 NIN	3.20e-05	1492	137	21	M40023
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	EPB41L5 NFKBIZ ITGA2 ESYT2 NR3C2 RAPGEF2 NFAT5 ZNF292	3.98e-05	240	137	8	M39236
Coexpression	GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	SP100 ITGA2 ITGAM DUSP16 CLSPN KLRG1 KNL1	4.03e-05	176	137	7	M9137
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	NTRK2 SMC5 LRRC8D UBR5 SYNE2 CEP295 CLSPN PCM1 PIF1 NOVA1 KNL1	4.52e-08	192	136	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	NTRK2 ADGRB3 EPB41L5 SMC5 LRRC8D UBR5 SYNE2 NUP210 PAPPA CEP295 CLSPN USF2 PCM1 PIF1 NOVA1 KNL1	1.30e-07	498	136	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	EPB41L5 TXNDC17 IL17RC WDR76 LIN9 KRIT1 FUBP1 SYNE2 NUP210 ZFP91 MACF1 CEP295 RAPGEF2 CLSPN PIF1 NOVA1 ZNF292	2.71e-07	595	136	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SP100 MYO5A NTRK2 ADGRB3 EPB41L5 ZKSCAN2 SMC5 LRRC8D LIN9 USF3 UBR5 SYNE2 NUP210 PAPPA CEP295 CLSPN USF2 PCM1 PIF1 NOVA1 KNL1 ZNF292	3.23e-07	989	136	22	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	MYO5A SMC5 LRRC8D LIN9 USF3 SYNE2 CEP295 CLSPN PCM1 PIF1 KNL1 ZNF292	7.92e-07	311	136	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	MYO5A NTRK2 ADGRB3 EPB41L5 GTDC1 SMC5 LRRC8D LIN9 UBR5 SYNE2 NUP210 PAPPA CEP295 CLSPN PCM1 PIF1 NOVA1 KNL1 ZNF292	1.50e-06	831	136	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	NTRK2 ADGRB3 EPB41L5 SMC5 WDR76 LRRC8D SYNE2 NUP210 CLSPN NOVA1 ZNF292	3.56e-06	298	136	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	NTRK2 ADGRB2 ADGRB3 EPB41L5 ZKSCAN2 SMC5 LRRC8D CSF1R KIAA0825 UBR5 SYNE2 DUSP16 NUP210 SCAPER PAPPA CLSPN CTSK HPCAL4 PIF1 NOVA1	4.57e-06	983	136	20	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NTRK2 ADGRB3 EPB41L5 LRRC8D KIAA0825 UBR5 SYNE2 DUSP16 NUP210 PAPPA NOVA1	8.84e-06	328	136	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	EPB41L5 REG3G NFKBIZ GCNT1 SCEL LIN9 WARS2 TASOR2 ADGRG6 DST NBEAL2 PKHD1 NR3C2 MAPK1 NFAT5 ZNF292 FAM149A	1.05e-05	780	136	17	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	NFKBIZ SMC5 LIN9 KRIT1 ADGRG6 SYNE2 MACF1 CEP295 RAPGEF2 CLSPN PCM1 ADGRA3 PIF1 KNL1 ZNF292	1.27e-05	629	136	15	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	NTRK2 EPB41L5 SMC5 LRRC8D SYNE2 PAPPA CLSPN PIF1 NOVA1	1.91e-05	232	136	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NTRK2 ADGRB3 EPB41L5 SMC5 LRRC8D DST KIAA0825 UBR5 SYNE2 DUSP16 NUP210 PAPPA CLSPN PIF1 NOVA1	2.00e-05	654	136	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3	SP100 ITGA2 SMC5 ITGAM TMEM71 ESYT2 CD19 ZNRF3 KLHL30 TNFSF8 KLRG1	2.84e-05	372	136	11	GSM538288_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	DONSON NTRK2 EPB41L5 SMC5 WDR76 CYRIB EXOC5 UBR5 ETAA1 PAPPA CLSPN QRSL1 NOVA1	3.87e-05	532	136	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	EPB41L5 LRRC8D SYNE2 NUP210 MACF1 LRRC8B	4.01e-05	98	136	6	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	DONSON MYO5A RTEL1 TXNDC17 SMC5 WDR76 LIN9 EXOC5 FUBP1 SYNE2 ETAA1 MACF1 PAPPA CEP295 RAPGEF2 CLSPN CPLANE1 PCM1 PIF1 KNL1 ZNF292	4.99e-05	1257	136	21	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	NTRK2 EPB41L5 SMC5 WDR76 NUP210 PAPPA QRSL1 NOVA1	5.21e-05	204	136	8	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_200	EPB41L5 GCNT1 ADGRG6 DST PKHD1 NFAT5 FAM149A	6.95e-05	157	136	7	gudmap_developingLowerUrinaryTract_e15.5_urothelium_200
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000	MYO5A NTRK2 B3GALNT2 EPB41L5 GCNT1 SCEL TMEM71 CYRIB ESYT2 CSF1R FUBP1 ZFP91 CLSPN NFAT5 GABRA4 NIN	9.16e-05	836	136	16	gudmap_developingKidney_e15.5_Podocyte cells_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	MYO5A RTEL1 ADGRB2 EPB41L5 LRRTM3 SMC5 ZNRF3 FUBP1 SYNE2 NUP210 MACF1 PAPPA CEP295 CLSPN PCM1 PIF1 KNL1 ZNF292	1.48e-04	1060	136	18	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4	EPB41L5 WDR76 NUP210 LRRC8B QRSL1 NOVA1	1.49e-04	124	136	6	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	DONSON MYO5A EPB41L5 SMC5 WDR76 LRRC8D LIN9 ZNF446 CCDC142 FUBP1 SYNE2 ETAA1 CEP295 LRRC8B CLSPN USF2 CPLANE1 PCM1 PIF1 KNL1 ZNF239	1.68e-04	1370	136	21	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SP100 NTRK2 ADGRB3 EPB41L5 ZKSCAN2 SMC5 WDR76 LRRC8D SYNE2 NUP210 MACF1 LRRC8B CLSPN USF2 PIF1 NOVA1 ZNF292	1.92e-04	986	136	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	SP100 NFKBIZ IL17RC LRRTM3 SMC5 LIN9 ZFHX4 SYNE2 MACF1 CEP295 CLSPN USF2 HPCAL4 PCM1 PIF1 KNL1 ZNF292	1.99e-04	989	136	17	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	LRRC8D LIN9 MACF1 CLSPN PCM1 PIF1 KNL1	1.99e-04	186	136	7	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4	EPB41L5 WDR76 SYNE2 NUP210 CLSPN NOVA1	2.56e-04	137	136	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	SP100 MYO5A RTEL1 NTRK2 ADGRB2 EPB41L5 LRRTM3 SMC5 ZNRF3 FUBP1 SYNE2 NUP210 PKHD1 MACF1 PAPPA CEP295 CLSPN PCM1 PIF1 KNL1 ZNF292	2.58e-04	1414	136	21	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	NTRK2 EPB41L5 LRRC8D SYNE2 NUP210 NOVA1	2.76e-04	139	136	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2	MYO5A NFKBIZ ITGAM ADGRG6 DST CSF1R DUSP16 MS4A14 MERTK CD180	3.42e-04	414	136	10	GSM854271_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	LRRC8D LIN9 EXOC5 MACF1 CLSPN PCM1 PIF1 KNL1	3.66e-04	271	136	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	MYO5A NFKBIZ LRRTM3 SCEL MOAP1 TASOR2 FOCAD ESYT2 DST ZFHX4 SYNE2 SCAPER ADGRA3 ZNF239 GABRA4	3.66e-04	850	136	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	DONSON MYO5A RTEL1 TXNDC17 SMC5 WDR76 LIN9 EXOC5 FUBP1 SYNE2 ETAA1 MACF1 PAPPA CEP295 RAPGEF2 CLSPN CPLANE1 PCM1 PIF1 KNL1 ZNF292	3.93e-04	1459	136	21	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4	ADGRB3 EPB41L5 NUP210 PAPPA NOVA1	4.02e-04	97	136	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	SP100 TMEM71 ITPR2 ESYT2 ZNRF3 TNFSF8 MACF1	4.16e-04	210	136	7	GSM403995_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500	NFKBIZ LRRTM3 SCEL TASOR2 DST ZFHX4 ZFP91 CTSK ZNF292 GABRA4	4.52e-04	429	136	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_200	EPB41L5 ADGRG6 PKHD1 CPLANE1 NFAT5 FAM149A	5.12e-04	156	136	6	gudmap_developingKidney_e15.5_cortic collect duct_200
CoexpressionAtlas	CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2	SP100 TMEM71 ITPR2 ESYT2 ZNRF3 TNFSF8 MACF1	6.11e-04	224	136	7	GSM403994_500
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000	MYO5A B3GALNT2 EPB41L5 SCEL CYRIB FUBP1 CLSPN NIN	6.12e-04	293	136	8	gudmap_developingKidney_e15.5_Podocyte cells_1000_k4
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_100	ADGRG6 NFAT5 FAM149A	6.72e-04	27	136	3	gudmap_developingKidney_e15.5_cortic collect duct_100_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	NTRK2 ADGRB3 EPB41L5 UBR5 NUP210 PAPPA NOVA1	7.33e-04	231	136	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3	SP100 TMEM71 FOCAD ESYT2 ZNRF3 TNFSF8 NBEAL2 MACF1	7.62e-04	303	136	8	GSM538398_500
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	TASOR2 EXOC5 USF3 ZFP91 LRRC8B CRYBG3 CPLANE1 VPS13B	1.63e-07	193	138	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRB3 ITPR2 FOCAD UBR5 SCAPER NR3C2 RAPGEF2 VPS13B	2.06e-07	199	138	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MYO5A NTRK2 LRRTM3 ITPR2 SHROOM4 ZFHX4 CRYBG3	1.76e-06	184	138	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 ITGA2 ESYT2 DST PKHD1 NR3C2 HPCAL4	1.96e-06	187	138	7	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WDR76 TMEM71 FCGBP CSF1R CLSPN PIF1 KNL1	1.96e-06	187	138	7	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5A ITGAM CYRIB FCGBP CSF1R MS4A14 MERTK	2.10e-06	189	138	7	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM ADGRG6 CSF1R TNFSF8 MS4A14 MERTK	2.34e-06	192	138	7	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ITPR2 ZNRF3 UBR5 SNTG1 NFAT5 PCM1 ZNF292	2.34e-06	192	138	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM ADGRG6 CSF1R TNFSF8 MS4A14 MERTK	2.34e-06	192	138	7	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DONSON WDR5 KIAA0825 ZNRF3 ABCB11 CLSPN ADGRA3	2.34e-06	192	138	7	d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ITPR2 ZNRF3 UBR5 SNTG1 NFAT5 PCM1 ZNF292	2.42e-06	193	138	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD35 MYO9B ITGAM SYNE2 MACF1 MAPK1 CLSPN	2.50e-06	194	138	7	24837a27b0041fe8c348225fa8b09b127d743603
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A MYO9B ITGAM CSF1R TNFSF8 MS4A14 MERTK	2.59e-06	195	138	7	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	MYO5A MYO9B ITGAM CYRIB CSF1R MS4A14 MERTK	2.77e-06	197	138	7	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	ZNF132 TRABD2A KRT73 SYNE2 DUSP16 MACF1 HPCAL4	2.86e-06	198	138	7	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPB41L5 ITGA2 SCEL NBEAL2 SYNE2 PKHD1 PLXNA1	2.96e-06	199	138	7	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 NFKBIZ ITGA2 PKHD1 SNTG1 MACF1 NFAT5	2.96e-06	199	138	7	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPB41L5 ITGA2 SCEL NBEAL2 SYNE2 PKHD1 PLXNA1	3.06e-06	200	138	7	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	MYO5A ITGAM ITPR2 CSF1R MACF1 MERTK USF2	3.06e-06	200	138	7	a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYO9B DST SCAPER MACF1 MERTK ZNF292	4.05e-06	135	138	6	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CFAP47 ADGRB2 LIN9 KIAA0825 CEP295 FAM149A	9.64e-06	157	138	6	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	WDR5 CCDC168 LRRC46 TNFSF8 MERTK HPCAL4	1.07e-05	160	138	6	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	Immune_cells-NK_cells\|World / Lineage and Cell class	SP100 ADGRB2 KLHL30 TNFSF8 NBEAL2 KLRG1	1.11e-05	161	138	6	3ef2e15b06286d94c18b71626aed456f681cc77b
ToppCell	CF-Myeloid-Neutrophil\|Myeloid / Disease state, Lineage and Cell class	LSMEM1 TMEM71 CYRIB KIAA0825 SYNE2 ZNF292	1.79e-05	175	138	6	8020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZKSCAN2 ITGAM GALNT8 NUP210 PIF1 KNL1	1.79e-05	175	138	6	f7d191cde68de8f3457fa62b1df53b6d0dbe5001
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ADGRB3 CCDC168 ADGRG6 PRELP NOVA1 FAM149A	1.84e-05	176	138	6	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ADGRB3 CCDC168 ADGRG6 PRELP NOVA1 FAM149A	1.84e-05	176	138	6	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCEL ADGRA2 KIAA0825 NBEAL2 NUP210 PLXNA1	1.90e-05	177	138	6	f6b9d91d46830d0d207b0abd4ee5a4942fd99774
ToppCell	facs-SCAT\|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NTRK2 ZFHX4 CTSK CDH9 PLXNA1 NOVA1	2.09e-05	180	138	6	6c70b6b7480507fa94625013222ad338ee7dd1d9
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 ADGRG6 PRELP PAPPA TLN2 NOVA1	2.09e-05	180	138	6	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SP100 NFKBIZ DST SYNE2 NFAT5 ZNF292	2.30e-05	183	138	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	MYO9B ITGAM SYNE2 MACF1 MAPK1 KLRG1	2.37e-05	184	138	6	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	Mild-CD4+_T\|Mild / Disease group and Cell class	TRABD2A NTRK2 TNFSF8 NR3C2 CRYBG3 HPCAL4	2.44e-05	185	138	6	c28ecb63146de1b02418e5a4fad0ae7c2b66a41d
ToppCell	Myeloid-B_(Activated_Macrophage)\|World / shred on cell class and cell subclass (v4)	MYO5A CYRIB ITPR2 DST MERTK CTSK	2.52e-05	186	138	6	33d731a7883d75e4e7db83b641cdb1e9a39938bf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WDR76 ADGRA2 LIN9 CLSPN PIF1 KNL1	2.59e-05	187	138	6	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	WDR76 ADGRA2 LIN9 CLSPN PIF1 KNL1	2.59e-05	187	138	6	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPB41L5 ITGA2 SCEL ZNRF3 SYNE2 PKHD1	2.59e-05	187	138	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 ITGA2 DST NBEAL2 PKHD1 NR3C2	2.59e-05	187	138	6	f124d2c699b717b7c02a1a70493f515b83dc2f4c
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TASOR2 EPG5 SYNE2 MACF1 RAPGEF2 NFAT5	2.67e-05	188	138	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 ITGA2 PKHD1 SNTG1 NR3C2 NFAT5	2.75e-05	189	138	6	90aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM6 ITGA2 DST NBEAL2 PKHD1 NR3C2	2.75e-05	189	138	6	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPB41L5 LRRTM3 SHROOM4 ZNRF3 PKHD1 NR3C2	2.84e-05	190	138	6	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	DONSON WDR76 LIN9 NUP210 CLSPN KNL1	2.84e-05	190	138	6	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MYO5A ITPR2 FCGBP CSF1R MERTK CD180	2.84e-05	190	138	6	cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM CSF1R TNFSF8 MS4A14 MERTK	2.92e-05	191	138	6	51f5af610983aa73b9f4ece6f27d281ebff89a04
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM CSF1R TNFSF8 MS4A14 MERTK	2.92e-05	191	138	6	8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	TRPM6 NFKBIZ ITGA2 PKHD1 SNTG1 NR3C2	3.01e-05	192	138	6	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE2 SCAPER PKHD1 MACF1 RAPGEF2 VPS13B	3.01e-05	192	138	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KRT73 SYNE2 SCAPER MACF1 VPS13B ZNF292	3.10e-05	193	138	6	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM CSF1R TNFSF8 MS4A14 MERTK	3.10e-05	193	138	6	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM ADGRG6 CSF1R TNFSF8 MS4A14	3.10e-05	193	138	6	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT1 ITGAM CSF1R TNFSF8 MS4A14 MERTK	3.10e-05	193	138	6	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	MYO5A ITGAM CYRIB CSF1R MS4A14 MERTK	3.19e-05	194	138	6	f09675cd472200363c458952f00d2e41990800ee
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NFKBIZ ITGA2 NBEAL2 PKHD1 NR3C2 NFAT5	3.19e-05	194	138	6	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NFKBIZ ITGA2 NBEAL2 PKHD1 NR3C2 NFAT5	3.19e-05	194	138	6	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	distal-1-Hematologic-IGSF21+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADGRB3 ITPR2 FCGBP CSF1R TNFSF8 MERTK	3.19e-05	194	138	6	f30c866e5f41ee79bdc6b6e08af962d62b199835
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TMEM71 ADGRG6 ITPR2 FCGBP CSF1R MERTK	3.19e-05	194	138	6	58046894446cb250814252a23f60fdd59c114d77
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADGRB2 SMC5 AP2B1 CEP295 PCM1 KNL1	3.19e-05	194	138	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	MYO5A MYO9B CYRIB ITPR2 CSF1R MERTK	3.28e-05	195	138	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.28e-05	195	138	6	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 LRRTM3 ADGRG6 DST ZFHX4 MACF1	3.28e-05	195	138	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	(3)_MNP-(3)_Macrophage_MARCOneg\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYO5A ADGRG6 ITPR2 FCGBP CSF1R MERTK	3.28e-05	195	138	6	e4b5e4b8832669fb4d1661ecd828b81e621d35c4
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TRABD2A DST TNFSF8 SYNE2 DUSP16 HPCAL4	3.28e-05	195	138	6	22191d361af136942508f1553ff41a626ed982ad
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A MYO9B ITGAM CSF1R MS4A14 MERTK	3.28e-05	195	138	6	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.38e-05	196	138	6	a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.38e-05	196	138	6	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.38e-05	196	138	6	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	proximal-mesenchymal-Myofibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRTM3 ADGRG6 PRELP PAPPA CTSK NOVA1	3.47e-05	197	138	6	ab21baea931ff134cf5a7ee369c091230988108b
ToppCell	proximal-mesenchymal-Myofibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRTM3 ADGRG6 PRELP PAPPA CTSK NOVA1	3.47e-05	197	138	6	15f2f169758a07143fc7d1bdb58d0b4d750a0be4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.47e-05	197	138	6	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO9B ITGAM CYRIB CSF1R MS4A14 MERTK	3.47e-05	197	138	6	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO9B ITGAM CYRIB ITPR2 CSF1R MERTK	3.47e-05	197	138	6	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	proximal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LRRTM3 ADGRG6 PRELP PAPPA CTSK NOVA1	3.47e-05	197	138	6	c59b64674fb4aaa945c1df7e4a9a3605c7cd2b75
ToppCell	COVID-19-Myeloid\|COVID-19 / group, cell type (main and fine annotations)	MYO5A MYO9B ITGAM CYRIB CSF1R MERTK	3.57e-05	198	138	6	33f0a919188a67d2a876b52c61a1cec2c9747969
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	EPB41L5 SCEL NBEAL2 SYNE2 PKHD1 PLXNA1	3.57e-05	198	138	6	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	Fetal_29-31_weeks-Immune\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO5A MYO9B ITGAM CYRIB ITPR2 CSF1R	3.57e-05	198	138	6	5dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	EPB41L5 SCEL NBEAL2 SYNE2 PKHD1 PLXNA1	3.57e-05	198	138	6	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	distal-2-Hematologic-Interstitial_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ITGAM CYRIB CSF1R TNFSF8 MS4A14 CD180	3.67e-05	199	138	6	d4caf296b6ce22a10b78d0efd4e018d867ccb78a
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SP100 SYNE2 MACF1 VPS13B PCM1 ZNF292	3.67e-05	199	138	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	CCDC168 WDR76 SHROOM4 GALNT8 CLSPN NOVA1	3.67e-05	199	138	6	e222b90caf45904d8f763574e7b6aac13333df92
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	NTRK2 DST ZFHX4 PRELP CTSK NOVA1	3.67e-05	199	138	6	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ITGAM TMEM71 CYRIB MAPK1 KLRG1 CAP1	3.67e-05	199	138	6	c3ee60602bdb166a5e67ba1c884dba88b934dfe1
ToppCell	Severe_COVID-19-Myeloid-MoAM4\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MYO5A ITGAM CSF1R MERTK USF2 CTSK	3.78e-05	200	138	6	30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CFAP47 NTRK2 ZFHX4 ZNRF3 ABCB11 MACF1	3.78e-05	200	138	6	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO5A ITGAM CSF1R MERTK USF2 CTSK	3.78e-05	200	138	6	4f481d87e30195365900acb5d50641a9e7b2f462
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYO5A ITGAM CSF1R MERTK USF2 CTSK	3.78e-05	200	138	6	5490393c5f54748f912676e19b58bd1320415a06
ToppCell	Parenchyma_Control_(B.)-Immune-TX-MoAM-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYO5A ITGAM FCGBP CSF1R MERTK CD180	3.78e-05	200	138	6	670ef1e68be0d2c6ea20ab4dea1d051a3cc89799
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SP100 NFKBIZ SYNE2 MACF1 PCM1 ZNF292	3.78e-05	200	138	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	TRABD2A SP100 DST SYNE2 DUSP16 HPCAL4	3.78e-05	200	138	6	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NTRK2 ADGRB3 ADGRG6 PRELP ADGRA3 NOVA1	3.78e-05	200	138	6	b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	ITGA2 WDR76 ZFHX4 SYNE2 CLSPN KNL1	3.78e-05	200	138	6	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	ITGA2 ZFHX4 SYNE2 CLSPN PIF1 KNL1	3.78e-05	200	138	6	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	ITGA2 WDR76 ZFHX4 SYNE2 CLSPN KNL1	3.78e-05	200	138	6	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYO5A ITGAM CSF1R MERTK USF2 CTSK	3.78e-05	200	138	6	cf720d3973e79ffd4c6e763a7284799ced22a274
ToppCell	BAL-Severe-Myeloid-MoAM-MoAM4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYO5A ITGAM CSF1R MERTK USF2 CTSK	3.78e-05	200	138	6	df821ac12953e44fcfedbbefb35a4976e406ccd6
ToppCell	Kidney-Fibroblasts\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	TOPAZ1 TMEM71 ZFHX4 PRELP LRRC8B CTSK	3.78e-05	200	138	6	2c265ad8314a21bce50ac21b16da2fea125366ea
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NTRK2 ADGRB3 ADGRG6 PRELP ADGRA3 NOVA1	3.78e-05	200	138	6	7c673ad0ea503ebd196579684d25d5f9e6a41030
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	LRRTM3 CSF1R KLHL30 ASIC4 MERTK CTSK	3.78e-05	200	138	6	be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CCDC168 SAMD7 ITGA2 KRT73	5.93e-05	68	138	4	ad6c363d7fb3c436e894db30a544748c5df75a45
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CCDC168 SAMD7 ITGA2 KRT73	5.93e-05	68	138	4	82d928f5eefa065d26096a84b0d78f131dcc8c73
Computational	Genes upregulated in subsets of cells of a given type within various tumors	SMC5 TASOR2 DST SYNE2 MACF1 PCM1	2.29e-06	50	84	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	geldanamycin	MYO5A EPB41L5 DST ZFHX4 PAPPA MAPK1 RAPGEF2 NFAT5 PCM1 ZNF669 KNL1	1.57e-05	371	137	11	ctd:C001277
Drug	Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; HL60; HG-U133A	NUP62 EDC4 ADGRA2 NUP210 RAPGEF2 USF2 PLXNA1 ZNF669	2.18e-05	192	137	8	1413_DN
Drug	0316684-0000 [391209-55-5]; Down 200; 10uM; PC3; HT_HG-U133A	SP100 ZBTB43 CYRIB AP2B1 SYNE2 RAPGEF2 NFAT5 PCM1	2.35e-05	194	137	8	7098_DN
Drug	Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SP100 WDR76 AP2B1 NUP210 SCAPER TLN2 NFAT5 ZNF669	2.35e-05	194	137	8	3274_DN
Drug	5666823; Down 200; 100uM; MCF7; HG-U133A	MYO9B ZBTB43 ZFHX4 NBEAL2 NUP210 TLN2 USF2 NOVA1	2.44e-05	195	137	8	609_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A	PPP1R14D KRIT1 UBR5 PRELP FUBP1 TLN2 NR3C2 USF2	2.44e-05	195	137	8	1944_UP
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A	EPB41L5 ZNF446 CYRIB ITPR2 ZFHX4 SCAPER MERTK USF2	2.44e-05	195	137	8	3376_DN
Drug	Piroxicam [36322-90-4]; Up 200; 12uM; PC3; HT_HG-U133A	SP100 ZBTB43 ITGA2 WDR76 ZNF446 ITPR2 NFAT5 HPCAL4	2.44e-05	195	137	8	2089_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	ZBTB43 ADGRB2 WDR76 ZNF446 FUBP1 NBEAL2 NUP210 USF2	2.44e-05	195	137	8	5117_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	DNAJB12 RTEL1 GCNT1 CSF1R NBEAL2 TLN2 USF2 PCM1	2.44e-05	195	137	8	2820_DN
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A	PLXNA3 GCNT1 ZFHX4 SCAPER TLN2 USF2 FBXO21 PCM1	2.53e-05	196	137	8	7328_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	DNAJB12 ADGRB2 ADGRB3 PPP1R14D ITPR2 FUBP1 PAPPA MERTK	2.53e-05	196	137	8	4281_UP
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	RTEL1 MYO9B NTRK2 WDR76 TLN2 MERTK KLRG1 VPS13B	2.53e-05	196	137	8	2888_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	RTEL1 MYO9B WDR76 KRIT1 UBR5 SCAPER USF2 NFAT5	2.63e-05	197	137	8	2870_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	SP100 MYO9B HMGXB4 NR3C2 LRRC8B USF2 PLXNA1 NOVA1	2.72e-05	198	137	8	5858_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; PC3; HT_HG-U133A	PAGE1 ZBTB43 ZNF446 CSF1R LRRC8B MAPK1 FBXO21 NOVA1	2.72e-05	198	137	8	2099_UP
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	ADGRB2 IL17RC ZNF446 CYRIB ITPR2 FUBP1 RAPGEF2 USF2	2.72e-05	198	137	8	5094_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	SP100 MYO9B GCNT1 CYRIB AP2B1 RAPGEF2 USF2 FBXO21	2.72e-05	198	137	8	6444_DN
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A	ZBTB43 CYRIB ADD1 NBEAL2 NUP210 MAPK1 PCM1 ZNF292	2.82e-05	199	137	8	6355_DN
Drug	Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	SP100 CYRIB CSF1R AP2B1 LRRC8B MERTK CTSK ZNF669	2.82e-05	199	137	8	2109_UP
Drug	Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A	ADGRB3 PPP1R14D IL17RC CYRIB ITPR2 CSF1R PCM1 NOVA1	2.93e-05	200	137	8	5445_UP
Drug	xestospongin C	ITGAM ITPR2 MAPK1	4.51e-05	12	137	3	ctd:C511704
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	DNAJB12 HMGXB4 NUP62 CYRIB ADGRG6 EXOC5 USF2	8.38e-05	172	137	7	4344_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	WDR76 NUP210 SCAPER MACF1 NR3C2 PLXNA1 VPS13B	1.00e-04	177	137	7	4652_DN
Drug	carbocyclic 2',3'-dideoxyadenosine	ITGA2 UBR5	1.07e-04	3	137	2	CID000255105
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	DNAJB12 NUP62 WARS2 PRELP NUP210 USF2 PLXNA1	1.08e-04	179	137	7	331_DN
Drug	5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one	NTRK2 MAPK1 MERTK	1.13e-04	16	137	3	ctd:C561052
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	DNAJB12 RTEL1 SCEL ADGRG6 AP2B1 NR3C2 NFAT5	1.23e-04	183	137	7	7088_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	ZCCHC8 HMGXB4 POLR3B LRRC8B RAPGEF2 VPS13B ZNF292	1.32e-04	185	137	7	1114_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	ZBTB43 EPB41L5 ZNF446 ITPR2 AP2B1 NUP210 USF2	1.61e-04	191	137	7	5200_DN
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; MCF7; HT_HG-U133A	RTEL1 ZBTB43 WDR76 CYRIB ZFHX4 SCAPER KLRG1	1.61e-04	191	137	7	3386_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DNAJB12 RTEL1 CYRIB SCAPER TLN2 NFAT5 VPS13B	1.66e-04	192	137	7	2873_DN
Drug	Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SP100 GCNT1 KRIT1 POLR3B ETAA1 MACF1 ZNF239	1.66e-04	192	137	7	4801_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	RTEL1 MYO9B EPB41L5 WDR76 RAPGEF2 PCM1 ZNF669	1.66e-04	192	137	7	4746_DN
Drug	Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A	ADGRB2 ZNF446 SCAPER TLN2 NR3C2 KLRG1 PCM1	1.71e-04	193	137	7	3712_DN
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	DNAJB12 NTRK2 EDC4 ITPR2 TLN2 MERTK FAM149A	1.71e-04	193	137	7	6678_UP
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; HL60; HG-U133A	MYO5A NUP62 EDC4 NUP210 MACF1 RRP7A PLXNA1	1.77e-04	194	137	7	1424_DN
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A	ADGRB2 NBEAL2 TLN2 USF2 KLRG1 QRSL1 PCM1	1.77e-04	194	137	7	4492_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	DNAJB12 CYRIB SCAPER RAPGEF2 USF2 CPLANE1 FBXO21	1.77e-04	194	137	7	4529_DN
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MYO9B WDR76 NUP210 TLN2 USF2 PLXNA1 ZNF669	1.83e-04	195	137	7	3461_DN
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A	RTEL1 MYO9B ZBTB43 EPB41L5 GTDC1 NBEAL2 USF2	1.89e-04	196	137	7	5350_UP
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	EPB41L5 GTDC1 CYRIB FOCAD NUP210 TLN2 ZNF292	1.89e-04	196	137	7	3453_DN
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SP100 AP2B1 SCAPER QRSL1 PCM1 ZNF669 ZNF292	1.89e-04	196	137	7	3222_DN
Drug	cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A	MYO9B ZBTB43 MOAP1 KRIT1 UBR5 SNTG1 USF2	1.89e-04	196	137	7	379_UP
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	SP100 ADGRB2 ADGRA2 CSF1R FUBP1 CPLANE1 FBXO21	1.89e-04	196	137	7	6402_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	DNAJB12 ETAA1 TLN2 NR3C2 FBXO21 ZNF669 NOVA1	1.89e-04	196	137	7	2086_UP
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	SP100 EPB41L5 IL17RC ZNF446 EXOC5 FUBP1 MACF1	1.89e-04	196	137	7	2628_DN
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A	CYRIB TLN2 MERTK USF2 NFAT5 PLXNA1 VPS13B	1.89e-04	196	137	7	2834_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	DNAJB12 ITGA2 GCNT1 EDC4 ITGAM MACF1 RAPGEF2	1.89e-04	196	137	7	2978_DN
Drug	Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A	NTRK2 IL17RC GCNT1 ZFHX4 PRELP MERTK KLRG1	1.89e-04	196	137	7	3253_UP
Drug	Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	RTEL1 GTDC1 CSF1R SCAPER MAPK1 USF2 PCM1	1.89e-04	196	137	7	5081_DN
Drug	Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; PC3; HT_HG-U133A	DNAJB12 NTRK2 PPP1R14D ITPR2 SCAPER TLN2 FBXO21	1.89e-04	196	137	7	3994_UP
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; HL60; HT_HG-U133A	RTEL1 NTRK2 ITGA2 ADGRG6 PAPPA NR3C2 KLRG1	1.95e-04	197	137	7	2129_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	SP100 ZBTB43 ITGA2 SMC5 CYRIB NUP210 USF2	1.95e-04	197	137	7	1048_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	RTEL1 GCNT1 CYRIB ITPR2 MERTK RAPGEF2 ZNF669	1.95e-04	197	137	7	1508_DN
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A	DNAJB12 PLXNA3 SP100 MYO9B CSF1R ZFHX4 MERTK	1.95e-04	197	137	7	4767_DN
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	RTEL1 MYO9B IL17RC FUBP1 NUP210 USF2 QRSL1	1.95e-04	197	137	7	7306_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	SP100 MYO9B EXOC5 NUP210 SCAPER MACF1 PCM1	1.95e-04	197	137	7	5482_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	RTEL1 MYO9B ZBTB43 ADGRB2 GTDC1 NBEAL2 NUP210	2.01e-04	198	137	7	6976_UP
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; PC3; HT_HG-U133A	PLXNA3 ZBTB43 CSF1R AP2B1 SNTG1 MERTK USF2	2.01e-04	198	137	7	2107_UP
Drug	Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; HL60; HT_HG-U133A	DNAJB12 RTEL1 ZBTB43 CSF1R NFAT5 PLXNA1 PCM1	2.01e-04	198	137	7	2381_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SP100 NTRK2 ZBTB43 MERTK KLRG1 PLXNA1 PCM1	2.01e-04	198	137	7	4970_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	DNAJB12 ADGRB2 GCNT1 NUP210 TLN2 MERTK KLRG1	2.01e-04	198	137	7	3738_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	NTRK2 ADGRB2 IL17RC ITGAM MERTK HPCAL4 VPS13B	2.01e-04	198	137	7	2216_UP
Drug	Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ADCY10 ADGRA2 ZFHX4 SCAPER ETAA1 FBXO21 NOVA1	2.01e-04	198	137	7	4142_UP
Drug	Bethanechol chloride [590-63-6]; Up 200; 20.4uM; PC3; HT_HG-U133A	DNAJB12 MYO9B NTRK2 ZBTB43 EPB41L5 ETAA1 CPLANE1	2.01e-04	198	137	7	5114_UP
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A	SP100 RTEL1 EPB41L5 ITGA2 GTDC1 CYRIB USF2	2.01e-04	198	137	7	1506_DN
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	SP100 ZBTB43 IL17RC ZNF446 CYRIB ETAA1 MERTK	2.01e-04	198	137	7	2640_DN
Drug	N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	DNAJB12 ZBTB43 ADGRB2 EPB41L5 ZNF446 PLXNA1 PCM1	2.01e-04	198	137	7	842_UP
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; HL60; HG-U133A	SMC5 ITGAM ADGRA2 KRIT1 SCAPER PCM1 ZNF292	2.01e-04	198	137	7	1551_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	SP100 RTEL1 MYO9B EPB41L5 SCAPER NFAT5 PLXNA1	2.07e-04	199	137	7	5207_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SP100 RTEL1 EPB41L5 CYRIB ADD1 CSF1R NUP210	2.07e-04	199	137	7	1502_DN
Drug	Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ADGRB3 ITGAM CYRIB CSF1R MERTK KLRG1 VPS13B	2.07e-04	199	137	7	6815_UP
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	DNAJB12 GTDC1 CYRIB ADD1 KRIT1 SCAPER QRSL1	2.07e-04	199	137	7	4778_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; HL60; HT_HG-U133A	MYO9B ITGA2 SCAPER NFAT5 PLXNA1 PCM1 ZNF292	2.07e-04	199	137	7	2349_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; PC3; HT_HG-U133A	DNAJB12 LUZP4 CSF1R PRELP SCAPER MERTK USF2	2.07e-04	199	137	7	2092_UP
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	PLXNA3 ITGA2 KRIT1 ETAA1 RAPGEF2 USF2 NFAT5	2.07e-04	199	137	7	1528_DN
Drug	Gliclazide [21187-98-4]; Down 200; 12.4uM; HL60; HG-U133A	NTRK2 CYRIB KRIT1 EXOC5 UBR5 USF2 CTSK	2.13e-04	200	137	7	1720_DN
Drug	Ipratropium bromide [22254-24-6]; Down 200; 9.8uM; PC3; HT_HG-U133A	EDC4 ITPR2 NUP210 MACF1 USF2 CTSK PCM1	2.13e-04	200	137	7	5823_DN
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A	SP100 MYO9B NTRK2 ZNF446 FUBP1 GALNT8 HPCAL4	2.13e-04	200	137	7	6023_UP
Drug	CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A	DNAJB12 EPB41L5 PPP1R14D GTDC1 CYRIB RAPGEF2 NFAT5	2.13e-04	200	137	7	7544_DN
Disease	cognitive inhibition measurement	TRPM6 GCNT1 ADGRG6 SNTG1 PIF1	3.22e-06	50	134	5	EFO_0007969
Disease	primary microcephaly (implicated_via_orthology)	RRP7A KNL1	6.12e-05	3	134	2	DOID:0070297 (implicated_via_orthology)
Disease	colon adenocarcinoma (is_implicated_in)	CSF1R UBR5 MAPK1	2.21e-04	26	134	3	DOID:234 (is_implicated_in)
Disease	nucleotide measurement	TMCO5A ITGA2 GTDC1 SYNE2	3.47e-04	73	134	4	EFO_0010513
Disease	glioblastoma multiforme	RTEL1 POLR3B	7.22e-04	9	134	2	EFO_0000519
Disease	gastric adenocarcinoma (is_implicated_in)	RTEL1 UBR5	1.10e-03	11	134	2	DOID:3717 (is_implicated_in)
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment	HMGXB4 WARS2 ZNRF3 ETAA1	1.36e-03	105	134	4	EFO_0007788, EFO_0008007, EFO_0008343
Disease	superior parietal cortex volume measurement	ADGRB3 MAPK1	2.07e-03	15	134	2	EFO_0010330
Disease	abdominal fat cell number	C4orf17 CSF1R SNTG1 CDH9 ZNF669	2.15e-03	198	134	5	EFO_0021534
Disease	teratocarcinoma-derived growth factor 1 measurement	MYO5A NTRK2	2.36e-03	16	134	2	EFO_0008297
Disease	pro-hydroxy-pro measurement	TRPM6 NR3C2	2.36e-03	16	134	2	EFO_0021132
Disease	primary autosomal recessive microcephaly (is_implicated_in)	RRP7A KNL1	2.36e-03	16	134	2	DOID:0070296 (is_implicated_in)
Disease	age at menopause	NUP62 ADGRA2 TASOR2 ESYT2 ZFHX4 ETAA1	2.63e-03	302	134	6	EFO_0004704
Disease	Astrocytosis	ITGA2 MAPK1	2.66e-03	17	134	2	C3887640
Disease	Gliosis	ITGA2 MAPK1	2.66e-03	17	134	2	C0017639
Disease	glucuronate measurement	EPB41L5 MAPK1	2.99e-03	18	134	2	EFO_0010486
Disease	susceptibility to vaginal yeast infection measurement	NTRK2 PKHD1 TLN2	3.26e-03	65	134	3	EFO_0008412
Disease	cortical surface area measurement	TRPM6 MYO9B ADGRA2 WARS2 FOCAD KIAA0825 PKHD1 MACF1 PAPPA TLN2 NR3C2 CD180 CTSK NOVA1	3.27e-03	1345	134	14	EFO_0010736
Disease	diet measurement, HOMA-B	DUSP16 NFAT5	3.33e-03	19	134	2	EFO_0004469, EFO_0008111
Disease	age at onset, smoking initiation	SCEL ITPR2	3.33e-03	19	134	2	EFO_0004847, EFO_0005670
Disease	magnesium measurement	TRPM6 CCDC168 ITGA2	3.40e-03	66	134	3	EFO_0004845
Disease	obstructive sleep apnea	WARS2 SCAPER SNTG1	3.40e-03	66	134	3	EFO_0003918
Disease	BMI-adjusted waist-hip ratio, physical activity measurement	WARS2 ZNRF3 ETAA1	3.86e-03	69	134	3	EFO_0007788, EFO_0008002
Disease	waist-hip ratio	VPS11 MYO9B NTRK2 HMGXB4 WDR5 SCEL ZNF446 WARS2 ZNRF3 SYNE2 ETAA1 NFAT5 KNL1	3.92e-03	1226	134	13	EFO_0004343
Disease	Cleft palate	SCAPER KLRG1 PCM1	4.18e-03	71	134	3	HP_0000175
Disease	Intellectual Disability	ZCCHC8 NUP62 SHROOM4 POLR3B SCAPER MACF1 ZNF292	4.42e-03	447	134	7	C3714756

Protein segments in the cluster

Peptide	Gene	Start	Entry
QKITNCEQSSPDGAL	TMCO5A	111	Q8N6Q1
EDSPDSCKNGQLQIL	ADGRB2	1226	O60241
TGKLLNLSPQNLVDC	CTSK	156	P43235
DEQHQCSLGNLKVPL	ESYT2	606	A0FGR8
DKQGLVCSSEVPQNV	EPG5	181	Q9HCE0
PQNINKLLTALNECT	AP2B1	201	P63010
LSNSEKCQVLPGSEA	CRYBG3	736	Q68DQ2
LGPCKLTNLQLAQSQ	ADGRA2	1131	Q96PE1
PLNEQTEGCLTQELQ	ADGRB3	221	O60242
ACSIGNITIQNLKDP	ADGRG6	771	Q86SQ4
QAQPVTGVKQELLTC	ADGRA3	221	Q8IWK6
SQCQQPAENKLSDLL	CAP1	91	Q01518
ELQELQIPGKACVNN	ABCB11	96	O95342
QALGQASLPQECEKE	CCDC142	336	Q17RM4
QGCPKDLLAESTQEL	ANKRD35	371	Q8N283
QPNDISNKICLDLNV	ADCY10	701	Q96PN6
LQSQAFKECPQLELL	CD180	411	Q99467
PGLCQQNSQELLEPK	C2orf73	221	Q8N5S3
PINLQEKQVICLSGD	EDC4	71	Q6P2E9
SNIELLDNPGCKEVN	ITPR2	196	Q14571
LNGQPLIEQEKCSDN	LUZP4	106	Q9P127
ADSQELVQPKTGCEL	PAGE1	61	O75459
TCLAGDLLQVQPEQS	KLHL30	181	Q0D2K2
IEPLGLDEQQCSQKA	NUP210	66	Q8TEM1
CNPLSDISLKDIQAQ	FBXO21	206	O94952
SPSQEDLNCIINLKA	MAPK1	246	P28482
KDCPSGILNLEEFQQ	HPCAL4	36	Q9UM19
LLQNIINIKNECSPV	NFKBIZ	216	Q9BYH8
GQPCVENENLTDLIS	LIN9	451	Q5TKA1
QGSSKEKQELLPCLQ	NR3C2	61	P08235
TCEKRQETNGQPQGL	MAGEB6	11	Q8N7X4
DLNNCKNNLEPILEG	KRT73	171	Q86Y46
EIQSEINKQCPGVQL	KIAA0825	51	Q8IV33
NCSIQVKEADPLSNG	MERTK	316	Q12866
GKVNPQTQSLLAECG	FAM149A	296	A5PLN7
NLLKQLPDAICQAQA	LRRIQ4	431	A6NIV6
IQQESGCKIQIAPDS	FUBP1	126	Q96AE4
NCEPIGTQASKLEEQ	DST	5526	Q03001
PIENLVDSICNNILK	FSIP2	5186	Q5CZC0
LKINNPLITVDECLQ	MOAP1	221	Q96BY2
EKIQALQTACPDLQL	PCM1	761	Q15154
KTLTLNCVNPENENA	PLXNA1	1501	Q9UIW2
ENEGSAQVPVKVLNC	PLXNA3	1486	P51805
LNIIENSSAPICENK	KNL1	1501	Q8NG31
DQQGRSPLNICEENK	KRIT1	386	O00522
LAVCLNESPGQNQKE	GABRA4	26	P48169
NESPGQNQKEEKLCT	GABRA4	31	P48169
NKIQQIENLACIPSL	LRRC46	76	Q96FV0
ISTLGLQELKEQSPC	ASIC4	491	Q96FT7
GCPKQVLSNTLDNIA	HMGXB4	581	Q9UGU5
DTSDPLQQICKILNA	NUP62	466	P37198
GQCSVPNELNSNLKL	PAPPA	1476	Q13219
PNELNSNLKLQCPDG	PAPPA	1481	Q13219
DISCNADINPLKIGQ	ITGA2	1016	P17301
KTTGCNLDKVNIIPN	NFAT5	576	O94916
NNIENLPLQLFLCTK	LRRC8B	666	Q6P9F7
CETSGKLPSEQVLQQ	MACF1	2956	Q9UPN3
CILNQSIKAPVNTDL	ETAA1	536	Q9NY74
SNSLKNTGELQEPCV	PASD1	461	Q8IV76
VAPDNLKQVCSGEQL	EXOC5	666	O00471
LTCCEQGDIAQPLLQ	CSF1R	951	P07333
EKCLNNVIESPGLNV	EPB41L5	541	Q9HCM4
INKNGLQASSCEVPL	KLRG1	166	Q96E93
DCLNQTLELKSINGE	CPLANE1	821	Q9H799
AALKQGQITPTELCQ	QRSL1	11	Q9H0R6
LQCLKGTSDGPTQQL	CD19	36	P15391
GDCPKLDSLVAQQLQ	FCGBP	1046	Q9Y6R7
KNLLDENVCLDQGPV	GALNT8	501	Q9NY28
SCKLLNITNPVLNQE	B3GALNT2	111	Q8NCR0
CISIALKAIQSNQPD	DNAJB12	11	Q9NXW2
LDGTNKLCQFSPVQE	DUSP16	436	Q9BY84
IKGLNNIPICTVNDD	C4orf17	41	Q53FE4
VPKLLCQDSESQIQQ	MS4A14	636	Q96JA4
VVDSINDLNKLNLCP	LSMEM1	21	Q8N8F7
KELTNCGLHPNTLEQ	DONSON	526	Q9NYP3
ENKNLPIENTTDCLS	CYRIB	211	Q9NUQ9
NQTKGLVPECLNTLC	CCDC168	1401	Q8NDH2
QNKENILESVLPCIL	CCDC168	3186	Q8NDH2
ENPSSDINCTKVLQG	GCNT1	51	Q02742
ENKQNLTVDPCDILG	GTDC1	261	Q4AE62
EKGLVSCQSDIPISQ	CEP295	1026	Q9C0D2
ENVCLLPDESIQKGQ	SCAPER	301	Q9BY12
VCENAKPGQLIQTVS	CDH9	496	Q9ULB4
NGDNEIILSPLQCTK	CFAP47	2591	Q6ZTR5
KDQPSILEQQILQLC	FOCAD	211	Q5VW36
PNLCVQVNSSEKLQL	IL17RC	436	Q8NAC3
NLGQNCITSLPEKVG	LRRC8D	781	Q7L1W4
QPVLQLVCGDTSLNE	OR10C1	181	Q96KK4
LCQVQGEETQKELPS	REG3G	21	Q6UW15
LIIQKIQEDPQSGSC	NOVA1	236	P51513
EEQKTQLEAILGNCP	PPP1R14D	106	Q9NXH3
CLQQKVNGILESPTG	RTEL1	31	Q9NZ71
QCPVSQLLQLKLGAQ	PIF1	466	Q9H611
ACGINPEKSILFQQS	WARS2	101	Q9UGM6
LCDKDGNITLNPSQT	TMEM71	81	Q6P5X7
ENQIGCLTPELSELK	SYNE2	1801	Q8WXH0
NEKPTTALANTCGEL	SAMD7	241	Q7Z3H4
NTIICASPKELQGVN	LRRTM3	336	Q86VH5
GNILQLNQTLEECVP	NIN	1361	Q8N4C6
KTGICLLQDGNQEPF	SNTG1	11	Q9NSN8
IISNFGQTPCQLLKE	NBEAL2	2326	Q6ZNJ1
AQLQKSKGPLSQLCD	SHROOM4	601	Q9ULL8
NSIEKINGTQICPND	PRELP	321	P51888
KLLVSCQEANAPEGN	PKHD1	2151	P08F94
GLTQTCETLKLQLPN	ITGAM	706	P11215
LQDIKTAGPQSQVLC	ADD1	511	P35611
AQVKPCLELSLQSGN	CLSPN	126	Q9HAW4
GDKPLEQVTNVSCLE	C17orf64	11	Q86WR6
CLNESSKNIPLANLQ	NTRK2	176	Q16620
TCGLVQSVELQEKPD	RRP7A	81	Q9Y3A4
EVLEGNPTVLCQKLN	ZBTB43	121	O43298
LSLQCEPATNTLPKN	RAPGEF2	996	Q9Y4G8
SNLGQLPEVCTTQKL	ZNF132	221	P52740
EQSPQSLIILEGKNC	TRAV10	26	A0A0B4J240
LCGTTQLDNEVPEKV	ZFHX4	21	Q86UP3
CPNNSVDLKLELLIN	TNFSF8	151	P32971
TNFCLDKLGQPLLNE	ZCCHC8	176	Q6NZY4
IPEQTTQLLKGLCTD	VPS11	556	Q9H270
GQDKAEQVLPTLSCT	TRPM6	1416	Q9BX84
EICKQPLENLQAGDS	SCEL	651	O95171
ENINFKQSELPVTCG	SP100	596	P23497
TCEPQSLVENLTQKL	ZNF292	1676	O60281
NPSQLQCSDNVKIVL	ZNF292	2656	O60281
PGTANCELKPQQSEL	TRABD2A	26	Q86V40
GPSLEECQKAQIFTQ	POLR3B	266	Q9NW08
SCLPDQEVINGSLIN	USF3	1066	Q68DE3
PQDSSQQDACLILVK	nan	16	Q96IR3
VQLSKIIPDCNADNS	USF2	256	Q15853
QLSCSVKEEPNVDGQ	ZNF446	161	Q9NWS9
TPQKLVESECLQANL	TXNDC17	101	Q9BRA2
CNILSPEVENNSVLK	TOPAZ1	211	Q8N9V7
FGQVGLCDLTQQPKE	WDR76	336	Q9H967
LESLEIKCSNPQVQL	VPS13B	1211	Q7Z7G8
SKVCELQLPDINLVN	VPS13B	2401	Q7Z7G8
NIIEQKGNPSAVCVE	ZNRF3	336	Q9ULT6
LITLCTQQAPGQKEC	TLN2	1351	Q9Y4G6
QKQCPQSGEEAVALV	ZKSCAN2	106	Q63HK3
PLTQGLELCVQNEQK	TASOR2	881	Q5VWN6
GSLQLICKSEPNTDQ	ZFP91	176	Q96JP5
ATCQNGQLKESLDPI	ZNF239	136	Q16600
ELKTTENCENLQPQI	SMC5	386	Q8IY18
ASGQCLKTLIDDDNP	WDR5	201	P61964
QAFLSNEKLPNLECI	UBR5	2301	O95071
LDLNENISTGLKPCE	ZNF669	176	Q96BR6
DNQPCINLIESKLGI	MYO5A	491	Q9Y4I1
LCNLPELTEGNLLKN	MYO9B	151	Q13459